| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $2.98 | - | - |
| Q1'26 | $3.12 | $3.36 | +7.8% |
| Q4'25 | $2.77 | $2.77 | -0.0% |
| Q3'25 | $2.63 | $2.68 | +2.0% |
| Q2'25 | $2.94 | $2.96 | +0.6% |
| Q1'25 | $2.81 | $2.80 | -0.3% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.7B | - | - |
| Q1'26 | $1.8B | $1.9B | +5.8% |
| Q4'25 | $1.7B | $1.6B | -1.1% |
| Q3'25 | - | $1.5B | - |
| Q2'25 | - | $1.7B | - |
| Q1'25 | - | $1.6B | - |
Market Data
CME is currently trading at $276.29, giving CME Group Inc. a market cap of 100.53B and a P/E ratio of 23.5. Today's range spans $275.64–$279.82, with shares opening at $277.42 and moving down $1.13 (0.4%) from the prior close. DailyIQ's technical score sits at 32/100 (SELL) with a news sentiment reading of 65/100.
Over the past year CME has traded between $257.17 and $329.16 - the current price is +7.4% off the 52-week low and -16.1% from the high. 22 analysts cover the stock with a Buy consensus and a mean 12-month target of $306.47 (range $230.00–$353.00), implying upside of +10.9%.
CME: large-cap, Financial Services, 100.53B market cap. (P/E: 23.5) Technical score 32/100 (SELL). Sentiment: bullish (65/100). Price: $276.29 (in the lower half of its 52-week range). Range: $257.17–$329.16. The SELL designation at this capitalization tier doesn't mean the stock is uninvestable - it means the risk/reward of buying dips hasn't been restored yet, and patience or an outright hedge is often the better posture until technical conditions improve.
When a large-cap Financial Services name with 100.53B in capitalization prints a SELL signal (32/100) alongside bullish news sentiment (65/100), the risk isn't just price depreciation — it's the loss of institutional sponsorship that makes recovery harder. At $276.29 (in the lower half of its 52-week range in the $257.17–$329.16 range), the structural support levels are where that sponsorship question gets answered.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).